Nova Pharma Solutions Bhd (XKLS:03006) 3-Year EBITDA Growth Rate : 0.00% (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Nova Pharma Solutions Bhd 3-Year EBITDA Growth Rate?

Nova Pharma Solutions Bhd's EBITDA per Share for the six months ended in Dec. 2023 was RM0.02.

During the past 12 months, Nova Pharma Solutions Bhd's average EBITDA Per Share Growth Rate was 209.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 9 years, the highest 3-Year average EBITDA Per Share Growth Rate of Nova Pharma Solutions Bhd was 17.60% per year. The lowest was -27.30% per year. And the median was -8.85% per year.

Competitive Comparison of Nova Pharma Solutions Bhd's 3-Year EBITDA Growth Rate

For the Engineering & Construction subindustry, Nova Pharma Solutions Bhd's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nova Pharma Solutions Bhd's 3-Year EBITDA Growth Rate Distribution in the Construction Industry

For the Construction industry and Industrials sector, Nova Pharma Solutions Bhd's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Nova Pharma Solutions Bhd's 3-Year EBITDA Growth Rate falls into.

Nova Pharma Solutions Bhd 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Nova Pharma Solutions Bhd (XKLS:03006) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Nova Pharma Solutions Bhd 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Nova Pharma Solutions Bhd's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Nova Pharma Solutions Bhd (XKLS:03006) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Construction » Nova Pharma Solutions Bhd (XKLS:03006) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

N/A

Address

Jalan USJ 25/1, Level 5, Suite C-5-1 & 2, Block C, Sky Park, One City, Subang Jaya, SGR, MYS, 47650

Website

http://www.novapharmasolutions.com

Nova Pharma Solutions Bhd provides engineering solutions to pharma and biotech industries. The company's reportable segments include Design fee, Post Design, & Other support fees. Design fee comprises conceptual designs which include user requirement specification, capacity analysis and process scheduling with detailed costing, list of deliverables, details specification of various equipment and processes. Post design fee comprise tendering and procurement support as well as the construction of a plant, & Other support fees comprise of services to assist a customer in the good manufacturing practice document review & gap analysis and assessment. It generates a majority of its revenue from the Design fee segment. Geographically, the company generates a majority of its revenue from Malaysia.

Nova Pharma Solutions Bhd (XKLS:03006) Headlines

No Headlines